Circ: Heart Failure

"Cardiometabolic HFpEF" should be designated "Adiposity-related HFpEF", says Milton Packer et al in Circ Heart Fail @bborlaugmd @gabrieleschiat1 ahajrnls.org/4lzYtiJ

🚨JUST PUBLISHED 🚨@CircOutcomes focus issue on #CardiovascularEpidemiology led by @KBreathettMD @NorrinaA @emilycob Epidemiology is at an inflection point where we must move from description toward action-oriented science 📖 Read here: ahajournals.org/toc/circpopout… @bnallamo

Kidney dysfunction is common after HT. In this review, we discuss mitigating strategies including immunosuppression & nephroprotective medications for HT recipients @shannonmdunlay @KBreathettMD @KhazanieHeart @RichardKCheng2 @elenamdonald @EMDeFilippisMD ahajrnls.org/4sO9XkR

🚨ICYMI: @CircOutcomes is inviting applications for an Associate Editor to join the new editorial team led by incoming EIC @kardiologykazi ⏰Apply by April 10 🔗Details and selection criteria: ahajournals.org/circpopoutcome… @AHAScience

Michael R. Bristow: The Consummate Physician-Scientist of this Generation ahajrnls.org/4lARgif

Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity ahajrnls.org/46Tjejd

📣 Call for Applicants! 📣 @CircOutcomes invites applications for an Associate Editor to join the journal’s new editorial team led by incoming Editor-in-Chief Dr. Dhruv Kazi @kardiologykazi 🗓Apply by April 10 🔗Learn more: ahajournals.org/circpopoutcome… @AHAScience

Does Connexin-43 Fill the Gap in Arrhythmogenic Cardiomyopathy? @AdamHelmsMD ahajrnls.org/4bqKWGx

Arterial Versus Mixed Venous Lactate Levels in 1526 Cardiac Intensive Care Patients @alex_rosenberg @CVandenbriele ahajrnls.org/4ctHTi2

MUTTON-HF is designed to evaluate the impact of an Indigenous medically tailored meal program on clinical outcomes for HF in Navajo Nation #ACC26 @lauren_eberly @IHSgov @PennLDI @Penncardiology ahajrnls.org/4uc3ZvO

Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis @IacopoOlivotto @AlessiaArgiro @aldoporcari @beamusumeci1 @TiniGiacomo @GSaturi @ItaloPorto2 ahajrnls.org/4aHsxoO

Clonal hematopoiesis studies suggest that anti-inflammatory therapies may benefit HF patients with residual inflammation despite GDMT @DLMANN_MD @washumedicine ahajrnls.org/3OJALUC

A case of peripartum cardiogenic shock from effusive-constrictive pericarditis on VA-ECMO due to metastatic angiosarcoma @rsampathkumarMD @mazenodish @UreyTony @JennyYangMD @UCSDCardiology ahajrnls.org/4rRZ8yp

Check out this report on how upright testing can highlight preload limitations not seen while supine during RHC @vkittipibul @FudimMarat ahajrnls.org/4as5hee

Etiology, Management, and Outcomes of Society for Cardiovascular Angiography and Interventions Stage B Cardiogenic Shock @JDawnAbbott @RyanTudinoMD ahajrnls.org/40quRu4

@PeikertA, @eosto1 & colleagues discuss cellular interactions, immunometabolic mechanisms, and cardiometabolic therapeutic strategies in HFpEF @vacca94 @gabrieleschiat1 @OSTOLab1 @MedUniGraz @ESCardioNews ahajrnls.org/4cEfKEN

Rapid Progression of Eosinophilic Myocarditis to Acute Fulminant Myocarditis in a Young Chinese Female: A Case Report ahajrnls.org/4aDIMBX

Connexin-43 gene therapy rescues arrhythmias, structure, and survival across diverse desmosomal cardiomypathies @JingZhang_UCSD @FabianZanella @mellis25 @FarahSheikhLab @UCSDHealth @UCSDCardFellows ahajrnls.org/46ffZCt

Advanced Life Support Medications in eCPR and the Limits of Causal Inference @JohannesGrand ahajrnls.org/4rrdEga

Carfilzomib-induced cardiogenic shock is a rare but potentially reversible complication with early recognition and intensive care @andres_96_15 ahajrnls.org/4amJ6Go